Disease Activity

Validating 10-joint juvenile arthritis disease activity score cut-offs for disease activity levels in non-systemic juvenile idiopathic arthritis
Maria Backström, Pirjo Tynjälä, Kristiina Aalto, Minna-Maija Grönlund, Heikki Ylijoki, Anne Putto-Laurila, Johanna Kärki, Paula Keskitalo, Sirja Sard, Heini Pohjankoski, Maiju Hietanen, Silke Witter, Helena Lehto, Eliisa Löyttyniemi, Paula Vähäsalo

RMD Open Apr 2019, 5 (1) e000888; DOI: 10.1136/rmdopen-2018-000888
Fosdagrocorat (PF-04171327) versus prednisone or placebo in rheumatoid arthritis: a randomised, double-blind, multicentre, phase IIb study
Frank Buttgereit, Vibeke Strand, Eun Bong Lee, Abraham Simon-Campos, Dorothy McCabe, Astrid Genet, Brinda Tammara, Ricardo Rojo, Judith Hey-Hadavi

RMD Open Apr 2019, 5 (1) e000889; DOI: 10.1136/rmdopen-2018-000889
Neural networks for automatic scoring of arthritis disease activity on ultrasound images
Jakob Kristian Holm Andersen, Jannik Skyttegaard Pedersen, Martin Sundahl Laursen, Kathrine Holtz, Jakob Grauslund, Thiusius Rajeeth Savarimuthu, Søren Andreas Just

RMD Open Mar 2019, 5 (1) e000891; DOI: 10.1136/rmdopen-2018-000891
Re-treatment with abatacept plus methotrexate for disease flare after complete treatment withdrawal in patients with early rheumatoid arthritis: 2-year results from the AVERT study
Paul Emery, Gerd R Burmester, Vivian P Bykerk, Bernard G Combe, Daniel E Furst, Michael A Maldonado, Tom WJ Huizinga

RMD Open Feb 2019, 5 (1) e000840; DOI: 10.1136/rmdopen-2018-000840
Peripheral disease contributes significantly to the level of disease activity in axial spondyloarthritis
Janneke J de Winter, Jacqueline E Paramarta, Henriëtte M de Jong, Marleen G van de Sande, Dominique L Baeten

RMD Open Jan 2019, 5 (1) e000802; DOI: 10.1136/rmdopen-2018-000802
Abatacept in combination with methotrexate in Japanese biologic-naive patients with active rheumatoid arthritis: a randomised placebo-controlled phase IV study
Tsukasa Matsubara, Hiroshi Inoue, Toshihiro Nakajima, Kazuhide Tanimura, Akira Sagawa, Yukio Sato, Kei Osano, Shuji Nagano, Yukitaka Ueki, Tadamasa Hanyu, Koichi Hashizume, Norihito Amano, Yoshiya Tanaka, Tsutomu Takeuchi

RMD Open Dec 2018, 4 (2) e000813; DOI: 10.1136/rmdopen-2018-000813
Uncovering the heterogeneity of disease impact in axial spondyloarthritis: bivariate trajectories of disease activity and quality of life
Maike Imkamp, Valéria Lima Passos, Annelies Boonen, Suzanne Arends, Maxime Dougados, Robert Landewé, Sofia Ramiro, Filip Van den Bosch, Desirée van der Heijde, Freke R Wink, Anneke Spoorenberg, Astrid van Tubergen

RMD Open Nov 2018, 4 (2) e000755; DOI: 10.1136/rmdopen-2018-000755
ACPA and RF as predictors of sustained clinical remission in patients with rheumatoid arthritis: data from the Ontario Best practices Research Initiative (OBRI)
Janet E Pope, Mohammad Movahedi, Emmanouil Rampakakis, Angela Cesta, John S Sampalis, Edward Keystone, Carter Thorne, Claire Bombardier

RMD Open Nov 2018, 4 (2) e000738; DOI: 10.1136/rmdopen-2018-000738
Predicting achievement of the treatment targets at 6 months from 3-month response levels in rheumatoid arthritis: data from real-life follow-up in the NOR-DMARD study
Vibeke Norvang, Joseph Sexton, Eirik K Kristianslund, Inge C Olsen, Till Uhlig, Gunnstein Bakland, Frode Krøll, Erik Rødevand, Ada Wierød, Tore K Kvien, Josef S Smolen, Daniel Aletaha, Espen A Haavardsholm

RMD Open Oct 2018, 4 (2) e000773; DOI: 10.1136/rmdopen-2018-000773
Comparative analyses of responsiveness between the Rheumatoid Arthritis Impact of Disease score, other patient-reported outcomes and disease activity measures: secondary analyses from the ARCTIC study
Karen Holten, Joseph Sexton, Tore K Kvien, Anna-Birgitte Aga, Espen A Haavardsholm

RMD Open Oct 2018, 4 (2) e000754; DOI: 10.1136/rmdopen-2018-000754

Main menu

Disease Activity

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

Disease Activity

Pages